OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1476

Showing 1-25 of 1476 citing articles:

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
Klaudia Jomová, Renáta Raptová, Suliman Yousef Alomar, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 10, pp. 2499-2574
Open Access | Times Cited: 844

Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 769

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 678

Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques
Ju‐Hyun Lee, Dun‐Sheng Yang, Chris N. Goulbourne, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 6, pp. 688-701
Open Access | Times Cited: 420

Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 250

Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 233

Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 166

The neuroimmune axis of Alzheimer’s disease
Mehdi Jorfi, Anna Maaser-Hecker, Rudolph E. Tanzi
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 165

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 143

Mouse Models of Alzheimer’s Disease
Miyabishara Yokoyama, Honoka Kobayashi, Lisa Tatsumi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 133

Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques
Ethan R. Roy, Gabriel S. Chiu, Sanming Li, et al.
Immunity (2022) Vol. 55, Iss. 5, pp. 879-894.e6
Open Access | Times Cited: 131

Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance
Jin Wang, Liang Li, Zhou Zhang, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1264-1279.e8
Open Access | Times Cited: 126

iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 119

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114

Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee
Steve Vucic, Kai-Hsiang Chen, Matthew C. Kiernan, et al.
Clinical Neurophysiology (2023) Vol. 150, pp. 131-175
Open Access | Times Cited: 105

The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Eleanor Drummond, Tomas Kavanagh, Geoffrey Pires, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 102

Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research
Yue Lü, Dongfang Cheng, Ben Niu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 454-454
Open Access | Times Cited: 97

Lecanemab: First Approval
Sheridan M. Hoy
Drugs (2023) Vol. 83, Iss. 4, pp. 359-365
Open Access | Times Cited: 86

Mild cognitive impairment among rural‐dwelling older adults in China: A community‐based study
Lin Cong, Yifei Ren, Yongxiang Wang, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 56-66
Open Access | Times Cited: 83

Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease
Joseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4967-4977
Open Access | Times Cited: 81

Engineered Extracellular Vesicles with SHP2 High Expression Promote Mitophagy for Alzheimer's Disease Treatment
Fang Xu, Yi Wu, Qianyu Yang, et al.
Advanced Materials (2022) Vol. 34, Iss. 49
Closed Access | Times Cited: 78

Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
Qian Shi, Cheng Chang, Afaf Saliba, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 27, pp. 5294-5313
Open Access | Times Cited: 74

Mitochondrial dysfunction in neurodegenerative disorders
Madelyn Klemmensen, Seth H. Borrowman, Colin Pearce, et al.
Neurotherapeutics (2023) Vol. 21, Iss. 1, pp. e00292-e00292
Open Access | Times Cited: 69

Page 1 - Next Page

Scroll to top